Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Why one health system invested in its PBM as GLP-1 costs surged
Drug spending is rising sharply, with high-cost GLP-1 medications driving nearly half of the incr | How RxSense helped a health system invest in its own PBM and take control of rising GLP-1 costs.
TL;DRAI
Beth Israel Lahey created InScript PBM to manage GLP-1 costs: achieved 62% prescription growth, costs below trend, 80% continuance. Healthcare insourcing pharmacy from vendors for cost control and clinical alignment—strategic play for operational independence in benefit management.
1,224 words~6 min read
